Janku Filip
Officer at GLUE
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jun 30, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- GLUEMonte Rosa Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale GLUENo planFeb 23, 2026 2026
Sold 9,189 shares at $19.50 ($179k)
Janku Filip, Chief Medical Officer
No 10b5-1 planSold 12.2% of holdings ($1.5M position)65,837 shares leftFollows a Form 144Filing
- 2 Form 144 notice GLUENoticeJun 23, 2026 +120 days
Filed to sell 11,845 shares ($221k)
Janku Filip, Officer
10b5-1 planFiling
- 3 Form 144 notice GLUENoticeJun 24, 2026 +1 day
Filed to sell 30,000 shares ($621k)
Janku Filip, Officer
10b5-1 planFiling
- 4 Form 4 sale GLUERoutineJun 24, 2026 same day
Sold 41,845 shares at $21.08 ($882k)
Janku Filip, Chief Medical Officer
10b5-1 planSold 41.1% of holdings ($2.1M position)59,992 shares leftFollows a Form 144Filing
- 5 Form 144 notice GLUENoticeJun 29, 2026 +5 days
Filed to sell 6,000 shares ($134k)
Janku Filip, Officer
10b5-1 plan0.7x usual sizeFiling
- 6 Form 4 sale GLUERoutineJun 29, 2026 same day
Sold 6,000 shares at $22.95 ($138k)
Janku Filip, Chief Medical Officer
10b5-1 planSold 9.1% of holdings ($1.5M position)59,992 shares left0.7x usual sizeFollows a Form 144Filing
- 7 Form 144 notice GLUENoticeJun 30, 2026 +1 day
Filed to sell 5,407 shares ($129k)
Janku Filip, Officer
10b5-1 plan0.7x usual sizeFiling
- 8 Form 4 sale GLUERoutineJun 30, 2026 same day
Sold 5,407 shares at $24.50 ($132k)
Janku Filip, Chief Medical Officer
10b5-1 planSold 8.2% of holdings ($1.6M position)60,612 shares left0.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 1, 2026 | GLUE | Chief Medical Officer | Form 4 sale | 5,407 | $132k | 8.2% | Routine | SEC |
| Jun 30, 2026 | Jun 30, 2026 | GLUE | Officer | Form 144 notice | 5,407 | $129k | Notice | SEC | |
| Jun 29, 2026 | Jun 30, 2026 | GLUE | Chief Medical Officer | Form 4 sale | 6,000 | $138k | 9.1% | Routine | SEC |
| Jun 29, 2026 | Jun 29, 2026 | GLUE | Officer | Form 144 notice | 6,000 | $134k | Notice | SEC | |
| Jun 24, 2026 | Jun 25, 2026 | GLUE | Chief Medical Officer | Form 4 sale | 41,845 | $882k | 41.1% | Routine | SEC |
| Jun 24, 2026 | Jun 24, 2026 | GLUE | Officer | Form 144 notice | 30,000 | $621k | Notice | SEC | |
| Jun 23, 2026 | Jun 23, 2026 | GLUE | Officer | Form 144 notice | 11,845 | $221k | Notice | SEC | |
| Feb 23, 2026 | Feb 24, 2026 | GLUE | Chief Medical Officer | Form 4 sale | 9,189 | $179k | 12.2% | No plan | SEC |
| Feb 23, 2026 | Feb 23, 2026 | GLUE | Officer | Form 144 notice | 9,189 | $179k | Notice | SEC | |
| Jan 5, 2026 | Jan 5, 2026 | GLUE | Chief Medical Officer | Form 4 sale | 3,155 | $48k | 4.0% | No plan | SEC |